Carol M. Black - Concepedia

Author

Carol M. Black

Also Known As

CAROL M. BLACK, CAROL M. BLACK, Carol Black, Carol M Black, Carol M. Black, Carol Mary Black, Ken Welsh, O'Huiginn, Brendan, Paschall, M. J., Robert Bernstein

229

Publications

19.4K

Citations

H-Index

192

Concepts

All Affiliations

University College London The Royal Free Hospital Royal Brompton Hospital Imperial College London Roland Hill (United Kingdom)

About

Carol M. Black is an author at University College London specializing in medicine, fibrosis, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	6	6	336
2	Education	4	4	262
3	Engineering	2	2	224
4	Language Studies	1	1	94
5	Law	1	1	80

Carol M. Black

117

Publications

18.3K

Citations

H-Index

Page 1

	Year	Citations
Bosentan Therapy for Pulmonary Arterial Hypertension Lewis J. Rubin, David B. Badesch, Robyn J. Barst, New England Journal of Medicine	2002	2.7K
Interstitial Lung Disease in Systemic Sclerosis Nicole Goh, Sujal R. Desai, Srihari Veeraraghavan, American Journal of Respiratory and Critical Care Medicine	2008	1.2K
Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome Demosthenes Bouros, Athol U. Wells, Andrew G. Nicholson, American Journal of Respiratory and Critical Care Medicine	2002	809
A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma Rachel K. Hoyles, R Ellis, Jessica Wellsbury, Arthritis & Rheumatism	2006	724
Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist J H Korn, Maureen D. Mayes, M Matucci Cerinic, Arthritis & Rheumatism	2004	720
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192 Christopher P. Denton, Peter A. Merkel, Daniel E. Furst, Arthritis & Rheumatism	2006	449
CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling Alan Holmes, David Abraham, Susan Sa, Journal of Biological Chemistry	2001	419
Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis Annemarie J. van der Slot, Anne‐Marie Zuurmond, A. Bardoel, Journal of Biological Chemistry	2003	401
CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia Sujal R. Desai, Srihari Veeraraghavan, David M. Hansell, Radiology	2004	387
Endothelin-1 Promotes Myofibroblast Induction through the ETA Receptor via a rac/Phosphoinositide 3-Kinase/Akt-dependent Pathway and Is Essential for the Enhanced Contractile Phenotype of Fibrotic Fibroblasts Shiwen Xu, Yunliang Chen, Christopher P. Denton, Molecular Biology of the Cell	2004	346

Page 1